Shandong Sinobioway Biomedicine Co Ltd (002581) — Cash Flow-to-Debt Ratio
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of CN¥-86.58 Million could theoretically repay 0% of its total liabilities (CN¥221.51 Million) in one year. See 002581 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sinobioway Biomedicine Co Ltd Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Shandong Sinobioway Biomedicine Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Shandong Sinobioway Biomedicine Co Ltd (002581) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)
Year-by-year debt coverage analysis for Shandong Sinobioway Biomedicine Co Ltd. Check 002581 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-6.55 Million | CN¥173.61 Million | ▲ +83.1% |
| 2023 | -0.22x | CN¥-36.51 Million | CN¥163.41 Million | ▼ -59.7% |
| 2022 | -0.14x | CN¥-54.49 Million | CN¥389.46 Million | ▲ +12.8% |
| 2021 | -0.16x | CN¥-46.02 Million | CN¥286.76 Million | ▼ -320.5% |
| 2020 | 0.07x | CN¥18.51 Million | CN¥254.33 Million | ▲ +54.1% |
| 2019 | 0.05x | CN¥48.41 Million | CN¥1.03 Billion | ▼ -6.5% |
| 2018 | 0.05x | CN¥74.46 Million | CN¥1.47 Billion | ▼ -79.9% |
| 2017 | 0.25x | CN¥271.11 Million | CN¥1.08 Billion | ▼ -76.2% |
| 2016 | 1.06x | CN¥169.32 Million | CN¥160.16 Million | ▲ +108.7% |
| 2015 | 0.51x | CN¥137.73 Million | CN¥271.92 Million | ▼ -87.3% |
| 2014 | 3.99x | CN¥80.11 Million | CN¥20.08 Million | ▲ +70.3% |
| 2013 | 2.34x | CN¥83.13 Million | CN¥35.49 Million | ▼ -8.5% |
| 2012 | 2.56x | CN¥63.04 Million | CN¥24.62 Million | ▼ -38.4% |
| 2011 | 4.15x | CN¥74.43 Million | CN¥17.91 Million | ▲ +56.7% |
| 2010 | 2.65x | CN¥85.71 Million | CN¥32.34 Million | ▲ +72.8% |
| 2009 | 1.53x | CN¥54.06 Million | CN¥35.24 Million | ▼ -10.3% |
| 2008 | 1.71x | CN¥46.89 Million | CN¥27.41 Million | ▼ -20.8% |
| 2007 | 2.16x | CN¥25.07 Million | CN¥11.60 Million | — |